Recordati Industria Chimica e Farmaceutica S.p.A. (0KBS)
LSE
Closed
Oct 7, 2026
Day's Range
52.9552 wk Range
43.78Overview - 0KBS - Recordati Industria Chimica e Farmaceutica S.p.A.
Key Statistics
Valuation
Enterprise Value
10.38B
P/E (Trailing)
‪28.50‬
Price / Sales (TTM)
‪5.49‬
Price / Book
‪6.76‬
EV / EBITDA
‪14.36‬
Profitability
Gross Margin
‪71.40%‬
Profit Margin
‪19.37%‬
Operating Margin
‪30.07%‬
Return on Assets
‪9.20%‬
Return on Equity
‪25.04%‬
Ownership
Shares Outstanding
204.81M
Float
98.94M
Held by Insiders
‪51.82%‬
Held by Institutions
‪26.86%‬
Price stats
Beta
‪0.33‬
50-Day Avg
‪52.23‬
200-Day Avg
‪49.89‬
Dividends
Payout Ratio
‪61.89%‬
Frequency
Semi-Annual
Market Cap - 0KBS - Recordati Industria Chimica e Farmaceutica S.p.A.
Peers - 0KBS - Recordati Industria Chimica e Farmaceutica S.p.A.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on LSE.
- 0KBSLSERecordati Industria Chimica e Farmaceutica S.p.A.11.00BMarket Cap+2.27%52-week change28.51P/E (Trailing)‪19.37%‬Profit Margin
- AZNLSEAstraZeneca PLC19.27TMarket Cap+9.73%52-week change24.57P/E (Trailing)‪17.02%‬Profit Margin
- GSKLSEGSK plc7.52TMarket Cap+19.52%52-week change16.10P/E (Trailing)‪14.52%‬Profit Margin
- SANLSESantander UK Plc Preferred Stock 10.375% Perpetual4.72TMarket Cap+98.91%52-week change0.38P/E (Trailing)‪19.73%‬Profit Margin
- 0QIULSENovo Nordisk A/S1.06TMarket Cap-37.73%52-week change17.11P/E (Trailing)‪33.39%‬Profit Margin
- 0Q1GLSEEli Lilly and Company984.08BMarket Cap+26.67%52-week change1.49P/E (Trailing)‪33.52%‬Profit Margin
- 0QCVLSEAbbVie Inc.476.72BMarket Cap+16.79%52-week change54.53P/E (Trailing)‪15.50%‬Profit Margin
Profile Summary - 0KBS - Recordati Industria Chimica e Farmaceutica S.p.A.
About
Recordati Industria Chimica e Farmaceutica S.p.A. is an international pharmaceutical company specializing in the development, manufacturing, and commercialization of innovative medicines across specialty and primary care, consumer healthcare, and rare diseases. Headquartered in Milan, Italy, it traces its origins to a…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
